Methdilazine

This classification denotes a vasodilating agent with the molecular formula C18H20N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4Q13LY9Z8X, chemically known as 10h-phenothiazine, 10-((1-methyl-3-pyrrolidinyl)methyl)- but generally known as methdilazine, which bears US NIH Compound Identifier 14677. European Medicines Agency schedules Methdilazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08844MIG. The term METHDILAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules methdilazine in its Anatomical Therapeutic Chemical (ATC) Classification. METHDILAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule methdilazine under HS 29343090 and SITC 51578. As of Q4 2014, METHDILAZINE remains the US FDA Preferred Term for this commodity. Methdilazine bears US NLM identifiers UMLS ID C0066101 and NCI Concept Code C66114. SMILES: S1C2C(N(CC3CCN(C3)C)C3C1CCCC3)CCCC2.